Previous 10 | Next 10 |
2023-10-25 09:25:00 ET Summary Bronte Capital is an Australian-licensed and USA SEC-registered Global Fund Manager and focuses on generating alpha from both its long and short portfolio in a unique, uncorrelated and sustainable manner. The Bronte Amalthea Fund achieved a 9.96% gai...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2023 financial results after the Nasdaq Global Market closes on Wednesday, Nov. 1, 2023. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to disc...
2023-10-18 11:05:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gene editing is revolutionizing how the world approaches medicine. In fact, by “simply” removing cells from the body, editing them, and reintroducing them, we could help treat sic...
2023-10-13 16:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-09-26 14:49:35 ET More on Sarepta Therapeutics Seeking Alpha’s Quant Rating on Sarepta Therapeutics Sarepta: Broad Label Expansion Possible With Q4 2023 Catalyst Sarepta Eyes Broadened Label For ELEVIDYS Amid Pro Sarepta Therapeutics: 'Hold' Amid ...
2023-09-24 12:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-09-22 13:50:35 ET More on Solid Biosciences Seeking Alpha’s Quant Rating on Solid Biosciences Historical earnings data for Solid Biosciences Financial information for Solid Biosciences For further details see: Solid Bio draws new Overweight ra...
2023-09-14 10:07:00 ET When investing in equities, even a relatively modest initial sum such as $500 can go a long way, provided investors pick the right stocks and continue adding to their positions regularly. Let's address the first part of this equation: Picking the right stocks. With my...
2023-09-13 15:31:39 ET Summary Sarepta Therapeutics, Inc. results from pivotal EMBARK study, using ELEVIDYS for the treatment of ambulatory DMD patients between ages 4 to 7 expected in Q4 of 2023. The primary endpoint being met in EMBARK study would allow label expansion for all a...
– Recipients include 20 individuals living with Duchenne muscular dystrophy and five siblings of individuals living with Duchenne Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced 25 recipients of Route 79,...
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...
2024-07-08 12:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...